发明名称 CONTROLLED RELEASE NUCLEATED TABLET
摘要 Disclosed is a controlled release nucleated tablet which is composed of an inner nucleus and an outer layer that covers the inner nucleus and is capable of maintaining the level of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid in the blood to a certain value or higher for a long period of time. The controlled release nucleated tablet is characterized in that the inner nucleus contains 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and the outer layer contains 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and a gel-forming water-soluble polymer that is in an amount of 16 (w/w) % or more relative to the weight of the outer layer.
申请公布号 US2013089609(A1) 申请公布日期 2013.04.11
申请号 US201113704345 申请日期 2011.06.15
申请人 FUJINAGA KENTARO;MARUO SUSUMU;NAKAMURA HIDEAKI;SUNAGAWA KENJI;MOCHIZUKI TSUTOMU;KAGEYAMA MICHIHARU;TEIJIN PHARMA LIMITED 发明人 FUJINAGA KENTARO;MARUO SUSUMU;NAKAMURA HIDEAKI;SUNAGAWA KENJI;MOCHIZUKI TSUTOMU;KAGEYAMA MICHIHARU
分类号 A61K9/28 主分类号 A61K9/28
代理机构 代理人
主权项
地址